by Combat Cancer | Oct 12, 2024 | News
A new study led by researchers from Weill Cornell Medicine and the New York Genome Center has provided unprecedented insights into the origins and progression of bladder cancer. Published on 9th October 2024 in Nature, the paper titled “The interplay of...
by Combat Cancer | Oct 4, 2024 | News
Chemotherapy can be tough on patients, but advancements in medical technology are making treatments more effective and less burdensome. One such innovation is a new implantable catheter system designed to facilitate optimal chemotherapy recirculation, ensuring that...
by Combat Cancer | Sep 28, 2024 | News
A recent study, which was written about in the mainstream media on 25th September 2024, highlights a worrying discovery (albeit known about for many years), about the everyday materials used in food packaging. Researchers have identified nearly 200 chemicals present...
by Combat Cancer | Sep 26, 2024 | News
Press release 26 September 2024 A new study published in the Journal of Surgical Oncology (August 9 2024) demonstrates that an implantable catheter system developed by Combat Medical facilitates optimal chemotherapy recirculation and maintains its functionality,...
by Combat Cancer | Sep 21, 2024 | News
At Combat Medical, we like to think that we are at the forefront of innovative cancer treatment technologies. Our primary focus is the development and delivery of chemo-hyperthermia therapy through HIVEC® (Hyperthermic Intravesical Chemotherapy). This cutting-edge...
by Combat Cancer | Sep 16, 2024 | News
A recent study published in European Urology Oncology (Liedberg et al., August 13, 2024) has found that prescribed treatments for urinary tract infections (UTIs) are associated with an increased risk of delayed diagnosis of advanced bladder cancer. This comprehensive...
Recent Comments